Secretion and metabolism of monomeric human calcitonin: Effects of age, sex, and thyroid damage
Authors:
Open Access
- 1 August 1986
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 1 (4) , 339-349
Abstract
Some data suggest that human calcitonin (CT) secretion is lower in women than in men, decreases with age and the menopause, and is absent in thyroidectomized persons. To further explore CT secretory physiology, we have studied basal and calcium-stimulated plasma immunoreactive CT (iCT) and silica-extractable monomeric CT concentrations in 148 healthy volunteers and 33 patients with a history of thyroid damage (total or subtotal thyroidectomy, radioiodine treatment for thyrotoxicosis). Both whole-plasma iCT and extractable CT levels were lower basally and after calcium infusion in women than in men, basal levels being reduced about 50% and calcium-stimulated values about 75% from those of male subjects. There were no significant changes in basal iCT or extractable CT concentrations with age, and CT secretory capacity (CT response to calcium infusion) likewise did not change with age. Infusion of monomeric CT to constant concentration in 27 persons permitted estimates of CT metabolic clearance rates (MCRs) and secretion rates (SRs). Calculated MCRs of about 9 ml/min · kg−1 (persons aged 21–30 yr) and 6 ml/min · kg−1 (persons aged 54–70 yr) were in good agreement with published data, and did not differ between the sexes. SRs were dependent upon the assay method used to estimate basal plasma CT concentrations, being highest when whole-plasma iCT values were used. Based on estimates of plasma monomeric CT from the silica extraction procedure, the SR of CT was 59 ± 6 (SE) ng/d · kg−1 in men, and 22 ± 3 ng/d · kg−1 in women. Thyroid damage reduced, but did not abolish, apparent CT immunoreactivity, even in silica extracts of plasma. However, all subsets of thyroiddamaged patients had absent-to-markedly-impaired CT secretion in response to calcium infusion. We conclude that CT secretion is substantially lower both basally and after stimulation in women than in men, and that this difference in CT immunoreactivity probably reflects differences in circulating CT bioactivity. The sex difference in plasma CT concentrations probably results from lower rates of CT secretion in women, not increased MCR. There is no age-related decrease of plasma CT concentrations (or CT secretory reserve), calling into question the concept that a progressive deficiency of CT is partly resonsible for age-related (“senile”) osteoporosis. Surgical or radiation damage to the thyroid gland commonly abolishes C-cell response to calcium; such CT-deficient patients form a population suitable for determining whether or not reduced CT secretion can impair skeletal homeostasis.Keywords
Funding Information
- National Institutes of Health (AM-32526, RR-585)
This publication has 27 references indexed in Scilit:
- Calcitonin Secretion in Postmenopausal OsteoporosisNew England Journal of Medicine, 1985
- Regulation of calcium‐regulating hormones by exogenous sex steroids in early postmenopauseEuropean Journal of Clinical Investigation, 1983
- Differential effects of endocrine dysfunction on the axial and the appendicular skeleton.Journal of Clinical Investigation, 1982
- CalcitoninNew England Journal of Medicine, 1981
- Influence of Age and Sex on Plasma Calcitonin in Human BeingsNew England Journal of Medicine, 1980
- RELATIVE DEFICIENCY OF PLASMA-CALCITONIN IN NORMAL WOMENThe Lancet, 1978
- Plasma Calcitonin in Normal ManJournal of Clinical Investigation, 1977
- Distribution of calcitonin‐containing cells in the human thyroidJournal of Anatomy, 1974
- Influence of posture on the serum concentration of calciumMetabolism, 1973
- Effects of glucagon, dibutyryl cyclic 3′,5′-adenosine monophosphate, and theophylline on calcitonin secretion in vitroJournal of Clinical Investigation, 1970